Alexandre Heraud

VC Investor

📍 Greater Paris Metropolitan Region, France🔄 Updated September 2026💼 26 investments📅 10 years investing🗓 Last invested Feb 2024
VC🌍 France20+ investments
26
Total investments
6
Early stage
12
Mid stage
7
Late stage
10y
Years active

Portfolio

25 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board observer
Feb 2024
Wir gestalten die Zukunft der urologischen Versorgung. Kranus Health bietet ein umfassendes Therapieangebot von der Andrologie bis zur Uro-Onkologie und erweitert aktiv sein Angebot an klinisch evidenzbasierten Behandlungen. ________________ Providing virtual care in urology. Kranus Health is providing a full range of therapies from Andrology to Uro-Oncology, actively broadening its array of virtual care journeys backed by clinical evidence. Urological conditions silently impact lives worldwide, often escaping widespread attention. Within this broad field, Andrology sheds light on the prevalent issue of erectile dysfunction, affecting a significant portion of adult males globally - 80 million in the US and EU alone. Despite its profound impact on relationships and self-esteem, it is frequently endured in silence. Prostate issues present other substantial challenges within urological health. Among them, prostate enlargement (BPH), which is the most common benign tumor found in men, affects more than 130 million in the EU and US, gradually straining healthcare systems and disrupting lives. Urology also encompasses the often-overlooked issue of incontinence, which affects roughly 200 million individuals globally, encompassing both men and women. Despite its prevalence, it remains largely sidelined in public discussions. Addressing these and other related pathologies, such as uro-oncology is crucial on a global scale. Its vital to ensure that everyone facing these challenges receives the understanding and support they need on their journey to healing.
Investor
Oct 2023
At Tilak, our vision is to transform the way we monitor chronic eye conditions. Our mission is to empower patients with fun and easy-to-use apps that help them (and their doctors’!) better manage their diseases. Founded in 2016 by Pr. José-Alain Sahel (opthalmologist) and Edouard Gasser (ex-Gameloft), Tilaks DNA combines medical expertise with gaming mastery. “You Play, We Care.” Our product is OdySight, the worlds first medical mobile app for vision monitoring supported by a national healthcare system. Since its launch on the French market in 2018, OdySight has been prescribed to 15 000 patients, most of which in France. OdySight is a CE marked medical device available in 5 languages and available on app stores in France, Spain, Belgium and the US.
Investor
Dec 2022
There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. Its going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldnt be a direct result of the surgeons state of mind. We believe its possible to create tools that will improve both patient outcome and surgeon experience. We believe its unacceptable to live in a world where *5 billion* people have no access to surgery whatsoever. We develop advanced robotics technologies for orthopedic surgeons. So that more people have access to life-changing orthopedic surgeries, safely and affordably. Freedom starts with movement. And we believe in what we do. Supported by A-Level entrepreneurs and innovators such as Bruno Maisonnier (Founder of Aldebaran Robotics, Founder & CEO AnotherBrain) and world-class orthopedic surgeons, we work hard to change the status quo in surgery. We are incubated at one of Europes best life science incubator, Paris Biotech Santé (ever heard of DNAScript, Therapenacea and Therapixel ? They are here too). We have raised significant seed money. We have gathered a world-class team. Were all in. Were still hiring.
Investor
Nov 2022
Show Your Teeth with Impress – Europe’s #1 Orthodontic Clinics Impress operates over 110 clinics across 10 countries in Europe and the United States, transforming orthodontic care with cutting-edge clear aligner treatments. Our clear aligners are the preferred choice for both orthodontists and patients, offering a seamless way to achieve aligned, healthy teeth with ease, discretion, and comfort. We believe in empowering individuals to show their teeth and face the world with confidence and self-assurance. With over 15 years of expertise, our skilled orthodontists partner closely with the Impress medical team to develop personalized treatment plans that deliver visible results in as little as 6 months. In 2024, we strengthened our leadership in the orthodontics industry by acquiring DR SMILE, furthering our mission to make high-quality orthodontic care accessible to an even wider audience. With ambitious plans to expand through new clinic openings and market entries, we’re committed to reshaping the future of oral health care. Join over 200,000 satisfied patients worldwide who have transformed their smiles with Impress. Ready to take the first step? Show your teeth with Impress today!
Board member
Jan 2022
Luko is one of the insurtech leader in France making home insurance simple and transparent. With Luko, you get insured in 2 minutes, you really understand what you pay for and can manage your contract and claim directly from your app. A seamless experience without the headaches: no paper, no engagement, no hidden cost!
mid stageInsurance
Board Observer
Jul 2021
PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors.
Investor
Jun 2021
At Ledger, we’re proud to be the global platform for digital assets and Web3, with over 20% of the world’s crypto assets secured through our Ledger devices. With our headquarters in Paris, and offices in Vierzon, Grenoble, Montpellier, London, Portland, Geneva, Zurich and Central Singapore, we have a team of around 600 professionals developing a variety of products and services to enable individuals and companies to securely buy, store, swap, grow and manage crypto assets – including the Ledger hardware wallets line with more than 7.5 millions units already sold in 200 countries. We’re a team of experts pushing the limits of what’s possible, united by our common goal to unlock true freedom through digital ownership, making technology accessible for all. We believe in a world where users, creators and enterprises manage their value with ownership and freedom. Our curiosity drives us to innovate, empowering individuals on a global scale. We believe change is constant and our team moves forward as one, with a culture of problem-solving where every employee is empowered and supported to challenge tradition and create solutions. Our mission is simple: to make self-custody accessible and give people the keys to their own financial futures. If you want to make a true impact, we want you to join us at Ledger.
Investor
Jan 2021
XENOTHERA is a biotechnology company based 21 rue La Nouë Bras de Fer, 44000 Nantes, France.
Board Member
Dec 2020
Imageens develops AI clinical decision-making softwares based on a prorietary technology that enables a better understanding of patient’s cardiovascular risk. Imageens’s technology measures new precision biomarkers that adresses several unmet medical needs, by making the most of cardiovascular imaging data. Starting off in cardiovascular prevention, we use our cutting-edge technology for a variety of other clinical areas with the mission to transform and save patients ‘s lives
Board Member
May 2020
SweepBright is a new generation CRM for forward looking real estate agencies. SweepBright empowers real estate agencies to deliver exceptional customer experiences and become significantly more efficient. SweepBright’s features save valuable time and costs by reducing manual data input and by making the entire sales process manageable on the go. SweepBright has been designed from the onset with a mobile usage in mind and integrates seamlessly with third-party applications. This enables agencies large or small to transform their sales flow into a fully digital journey and to deliver exceptional customer experiences. Creating a new listing takes a few minutes instead of hours. Publishing it to multiple advertising channels can be done with one tap while still on location. Matching leads and properties is smart and instantaneous which reduces spamming and results in higher conversion ratios. Tracking calls, emails or messages and associating them to a listing or lead occurs automatically. In short, SweepBright is "One App to Run Your Agency"​!
Board Member
Dec 2019
Bulldozair is a technology company backed by Y Combinator (US), Station F (EU) and Kima Ventures (EU). We provide a collaborative web and mobile platform that helps companies that own real estate or industrial assets to deliver their construction projects on time and on budget. Bulldozair digitally integrates all the owners construction process, compliance and checklists and deliver them to contractors and engineering teams. Owners follow their project progress on Dashboard and are alerted anytime there is a potential delay or technical risk and can collaborate online with those companies to solve problems. With their mobile application, construction consultants follow the owners process et collect data on the field (forms, measurements, pictures, plans...) that are uploaded directly on the clients cloud platform. All that communication between stakeholders is archived for traceability. All the legal and contractual reporting that took weeks is now done automatically. Bulldozair is now deployed across the biggest names of the corporate world in real estate, retail, manufacturing, energy, infrastructure...
Board Member
Oct 2019
A #traveltech startup, Smartrenting empowers travelers by removing the housing hurdle. Smartrenting is a real estate agency with an online platform for short-term rental and sublet for outbound travelers. There are countless situations that bring us to part with our apartment for a while : whether you head off to Hong Kong for an internship, to Phuket for holidays, or to Malta for a business trip, Smartrenting rents out your apartment, takes care of all things logistics from beautiful pictures to check-in/out and cleaning, and pays 100% of your rent. In short, Smartrenting provides owners and tenants alike with the safest and easiest way to save money while renting out their apartment. It’s legal, insured, and free of charge. Get to know us better : https://www.smart-renting.com
mid stageReal Estate
Board Member
Jun 2019
Founded in 2018, Posos is a MedTech company that has built the worlds most advanced artificial intelligence platform dedicated to medical prescriptions. It seamlessly integrates into a hospital’s electronic medical records, enabling healthcare prescribers to use AI to prescribe in real-time, based on the best recommendations. Co-created by Posos pharmacists and engineers, the platform has received approval from health authorities in France. Its powerful AI assistant speeds up and optimizes the prescribing process, which is currently very time-consuming and approximate within EHR. Posos can drive massive patient and economic impact, as demonstrated by the numerous EU institutions that have already adopted the solution.
Board Member
May 2019
Promoteurs immobiliers, Happywait digitalise le parcours d’achat dans limmobilier neuf de la signature électronique du contrat de réservation à la livraison du bien. - Gagnez du temps en supprimant les taches coûteuses et sans valeur ajoutée liées à l’Administration des ventes et au suivi des acquéreurs jusqu’à la livraison - Simplifiez la relation acquéreurs en dématérialisant les appels de fonds, les choix de matériaux, le chiffrage des options et le suivi des TMA - Augmentez vos ventes par recommandation en améliorant l’expérience d’achat de vos acquéreurs et en générant de la satisfaction grâce à lespace client - Evitez les doubles saisies et optez pour un logiciel ouvert qui sinterconnecte avec votre système dinformation (ERP, CRM,...) Une démo d’Happywait ? Un simple mail à : demo@happywait.com
Board Member
Dec 2018
MeilleureCopro est la société leader sur la maîtrise des charges de copropriété en France. Fondée en 2016, la société détient une connaissance unique du montant des charges et automatise des appels d’offres groupés sur l’ensemble des métiers de services en copropriété : Syndic, fourniture en énergie, maintenance multi-techniques, entretien, assurance etc. MeilleureCopro travaille main dans la main avec les promoteurs immobiliers, les syndics, et les conseils syndicaux pour alléger les charges de copropriété tout en assurant la qualité des prestations. Particulièrement novateur, MeilleureCopro a lancé le premier estimateur de charges en ligne permettant de comparer en 2 minutes ses charges de copropriété à celles dimmeubles comparables. Par ailleurs, dans le cadre de lattribution de la norme NF Habitat, MeilleureCopro a développé en partenariat avec Cerqual Qualitel Certification, le premier outil dévaluation de charges pour les copropriétés neuves. Forte de l’image et de la reconnaissance reçues par des associations de copropriétaires (UNPI 78) et de professionnels (membre FNAIM lab), MeilleureCopro qui a remis en concurrence plus de 3 000 contrats et a déjà accompagné plus de 500 copropriétés, a remporté le prix de linnovation de lannée au salon Rent 2019/2020 ! Dans le cadre de sa politique RSE au service des copropriétés, MeilleureCopro est signataire du Pacte Mondial des Nations Unies, et référence des prestataires de service partageant ses valeurs, pour une meilleure satisfaction des occupants d’immeubles.
early stageReal Estate
Show all 25 investments ↓
Experience · 31 entries
All (31)
Investments (26)
Board (17)
2024
Managing Partner
Sep 2024
We believe in entrepreneurial endeavours creating value and making the world a better place. We support early-stage to growth-stage companies transforming their industries and aiming to become global leaders. Our LPs are private and institutional investors and are often entrepreneurs themselves. They strongly value companies and people’s stories rather than investing over generic investment thesis of traditional venture capital investment funds.
Investor & Board observer
Feb 2024
Wir gestalten die Zukunft der urologischen Versorgung. Kranus Health bietet ein umfassendes Therapieangebot von der Andrologie bis zur Uro-Onkologie und erweitert aktiv sein Angebot an klinisch evidenzbasierten Behandlungen. ________________ Providing virtual care in urology. Kranus Health is providing a full range of therapies from Andrology to Uro-Oncology, actively broadening its array of virtual care journeys backed by clinical evidence. Urological conditions silently impact lives worldwide, often escaping widespread attention. Within this broad field, Andrology sheds light on the prevalent issue of erectile dysfunction, affecting a significant portion of adult males globally - 80 million in the US and EU alone. Despite its profound impact on relationships and self-esteem, it is frequently endured in silence. Prostate issues present other substantial challenges within urological health. Among them, prostate enlargement (BPH), which is the most common benign tumor found in men, affects more than 130 million in the EU and US, gradually straining healthcare systems and disrupting lives. Urology also encompasses the often-overlooked issue of incontinence, which affects roughly 200 million individuals globally, encompassing both men and women. Despite its prevalence, it remains largely sidelined in public discussions. Addressing these and other related pathologies, such as uro-oncology is crucial on a global scale. Its vital to ensure that everyone facing these challenges receives the understanding and support they need on their journey to healing.
2023
Investor
Oct 2023
At Tilak, our vision is to transform the way we monitor chronic eye conditions. Our mission is to empower patients with fun and easy-to-use apps that help them (and their doctors’!) better manage their diseases. Founded in 2016 by Pr. José-Alain Sahel (opthalmologist) and Edouard Gasser (ex-Gameloft), Tilaks DNA combines medical expertise with gaming mastery. “You Play, We Care.” Our product is OdySight, the worlds first medical mobile app for vision monitoring supported by a national healthcare system. Since its launch on the French market in 2018, OdySight has been prescribed to 15 000 patients, most of which in France. OdySight is a CE marked medical device available in 5 languages and available on app stores in France, Spain, Belgium and the US.
2022
Investor
Dec 2022
There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. Its going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldnt be a direct result of the surgeons state of mind. We believe its possible to create tools that will improve both patient outcome and surgeon experience. We believe its unacceptable to live in a world where *5 billion* people have no access to surgery whatsoever. We develop advanced robotics technologies for orthopedic surgeons. So that more people have access to life-changing orthopedic surgeries, safely and affordably. Freedom starts with movement. And we believe in what we do. Supported by A-Level entrepreneurs and innovators such as Bruno Maisonnier (Founder of Aldebaran Robotics, Founder & CEO AnotherBrain) and world-class orthopedic surgeons, we work hard to change the status quo in surgery. We are incubated at one of Europes best life science incubator, Paris Biotech Santé (ever heard of DNAScript, Therapenacea and Therapixel ? They are here too). We have raised significant seed money. We have gathered a world-class team. Were all in. Were still hiring.
Investor
Nov 2022
Show Your Teeth with Impress – Europe’s #1 Orthodontic Clinics Impress operates over 110 clinics across 10 countries in Europe and the United States, transforming orthodontic care with cutting-edge clear aligner treatments. Our clear aligners are the preferred choice for both orthodontists and patients, offering a seamless way to achieve aligned, healthy teeth with ease, discretion, and comfort. We believe in empowering individuals to show their teeth and face the world with confidence and self-assurance. With over 15 years of expertise, our skilled orthodontists partner closely with the Impress medical team to develop personalized treatment plans that deliver visible results in as little as 6 months. In 2024, we strengthened our leadership in the orthodontics industry by acquiring DR SMILE, furthering our mission to make high-quality orthodontic care accessible to an even wider audience. With ambitious plans to expand through new clinic openings and market entries, we’re committed to reshaping the future of oral health care. Join over 200,000 satisfied patients worldwide who have transformed their smiles with Impress. Ready to take the first step? Show your teeth with Impress today!
Show all 31 entries ↓
Investment activity
2016–2024 · 26 investments
20161201810201942020320213202232023120241
Recent (last 2 years)Earlier